Insight in United Kingdom

Published within

« | ... | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | ... | » »|

Type Product title / description Pub Price
Report
Report

Stakeholder Opinions: Hepatocellular cancer

Stakeholder Opinions: Hepatocellular Cancer discusses issues in the treatment of hepatocellular cancer, highlighting potential target populations for drug developers, treatment limitations and unmet needs, and an overview of the current pipeline.

Published By Datamonitor
01 Dec 2010 $2800
Buy
Report
Report

UK Value Clothing Retailers 2010

The value segment continues to outperform the clothing market. Worth £9.92bn in 2010 it accounts for 26.8% of the total clothing market, though growth is slowing. This report provides detailed analysis on the sector and its prospects for the future.

Published By Verdict
03 Dec 2010 $3450
Buy
Report
Report

UK Pet Insurance 2010

This report is a comprehensive guide to the UK pet insurance market, providing the reader with information on market size and growth, market shares of the leading competitors as well as discussions of current issues affecting the industry.

Published By Datamonitor
06 Dec 2010 $2795
Buy
Report
Report

Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive.

In-depth review of insulin developmental products for the treatment of diabetes, including an assessment of the commercial prospects of late-stage drugs, unmet market needs and sales forecasts to 2019.

Published By Datamonitor
08 Dec 2010 $3600
Buy
Report
Report

The Comfort Consumer Trend in Global Financial Services: Trust and Safety

The desire for protection and a need for safety is driven by uncertainty and stress. Trust lost as a result of the global downturn means consumers no longer trust their FS providers to offer financial safety; this lost trust must be restored.

Published By Datamonitor
08 Dec 2010 $3450
Buy
Report
Report

Forecast Insight: Antihypertensives - Fixed-dose combinations fail to offset generic erosion

Commercial analysis of the antihypertensive markets in the US, Japan, France, Germany, Italy, Spain, and the UK. Volume and revenue sales forecast to 2019.

Published By Datamonitor
08 Dec 2010 $6400
Buy
Report
Report

Forecast Insight: Depression - High rewards for novel and adjunctive therapies in treatment-resistant depression

Analysis of the current and future market for drugs treating depression. Includes sales forecasts to 2019 across the seven major markets (US, Japan, France, Germany, Italy, Spain and the UK) of key marketed brands, generics, and pipeline products.

Published By Datamonitor
09 Dec 2010 $6400
Buy
Report
Report

Pipeline Insight: Lung Cancers Overview – Intensive R&D activity but little improvement in patient outcomes

Overview of the current lung cancers clinical pipeline, including in-depth analysis of late-phase products, clinical trial data, sales forecasts through to 2019, Datamonitor drug assessment summaries and key opinion leader insight.

Published By Datamonitor
10 Dec 2010 $3600
Buy
Report
Report

Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitors bring added benefits to diabetes therapy.

In-depth review of non-insulin developmental products for the treatment of diabetes, including an assessment of the commercial prospects of late-stage drugs, unmet market needs and sales forecasts to 2019.

Published By Datamonitor
10 Dec 2010 $11400
Buy
Report
Report

Pipeline Insight: Cancer Overview Malignant Melanoma, Neuroendocrine Tumors and Thyroid Cancer - New drug approvals likely after decades of little progress

Overview of the current melanoma, thyroid cancer and neuroendocrine tumor pipelines, including in-depth analysis of late-phase products, sales forecasts through to 2019, Datamonitor drug assessment summaries and key opinion leader insight.

Published By Datamonitor
10 Dec 2010 $3600
Buy

« | ... | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | ... | » »|

No help is available.